KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
May 28, 2019 $60.18 $61.57 $59.60 $60.97 929 036
May 24, 2019 $58.45 $60.85 $58.23 $59.93 511 338
May 23, 2019 $57.47 $58.29 $56.61 $58.08 557 029
May 22, 2019 $57.96 $59.10 $57.09 $58.17 522 142
May 21, 2019 $57.20 $58.44 $56.51 $58.31 342 559
May 20, 2019 $58.00 $58.67 $56.69 $56.75 579 476
May 17, 2019 $60.50 $61.26 $58.51 $58.57 761 603
May 16, 2019 $58.19 $62.50 $58.19 $60.79 1 389 363
May 15, 2019 $57.00 $58.07 $56.56 $57.96 397 218
May 14, 2019 $55.19 $57.45 $55.13 $57.04 675 752
May 13, 2019 $57.49 $58.34 $54.55 $54.57 765 361
May 10, 2019 $57.80 $59.50 $57.41 $58.83 503 778
May 09, 2019 $57.07 $59.09 $54.75 $58.13 991 494
May 08, 2019 $55.54 $60.12 $55.00 $57.97 1 040 037
May 07, 2019 $55.79 $56.48 $54.28 $55.51 761 747
May 06, 2019 $54.03 $56.83 $53.85 $56.45 440 525
May 03, 2019 $54.48 $55.21 $53.26 $55.18 648 510
May 02, 2019 $53.45 $53.99 $52.60 $53.84 441 191
May 01, 2019 $55.79 $56.00 $53.41 $53.44 463 235
Apr 30, 2019 $55.39 $55.95 $53.60 $55.40 681 335
Apr 29, 2019 $56.44 $56.79 $55.01 $55.38 255 731
Apr 26, 2019 $57.00 $58.05 $56.25 $56.55 588 677
Apr 25, 2019 $55.31 $57.20 $55.00 $56.48 392 637
Apr 24, 2019 $56.46 $57.03 $55.18 $55.42 386 357
Apr 23, 2019 $54.08 $56.92 $53.47 $56.42 557 607
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT